Research Options: Select below IPO Calendar	Week of Expected Pricing Pending Company Name Advanced Biohealing Proposed Ticker ABHB CUSIP 00752T106 Business Description A leading regenerative medicine company that develops, manufactures and commercializes cell-based therapies. Lead Underwriter BofA Merrill Lynch,J.P. Morgan Securities LLC. Co-Managers Oppenheimer & Co,Wells Fargo Securities, LLC,William Blair and Co., L.L.C. Initial Shares 13,350,000 Revised Initial Shares N/A Initial Price $14.00-$16.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.